Cargando…
Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese
INTRODUCTION: This study aimed to investigate whether mononucleotide polymorphisms of the angiotensinogen gene at promoter were associated with the blood-pressure-lowering response to telmisartan treatment. MATERIALS AND METHODS: After a two-week single-blind placebo run-in period, 148 patients with...
Autores principales: | Gong, Hong-Tao, Mu, Li-Ying, Zhang, Tong, Xu, Xiu-Ying, Du, Feng-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362516/ https://www.ncbi.nlm.nih.gov/pubmed/30798697 http://dx.doi.org/10.1177/1470320319827205 |
Ejemplares similares
-
Association of Angiotensin-Converting Enzyme and Angiotensinogen Gene Polymorphisms with Preeclampsia
por: Choi, Hyunah, et al.
Publicado: (2004) -
The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013) -
Possible role for nephron‐derived angiotensinogen in angiotensin‐II dependent hypertension
por: Ramkumar, Nirupama, et al.
Publicado: (2016) -
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020) -
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014)